MyOr Overview
MyOr provides noninvasive monitoring technologies that use data-driven artificial intelligence to predict and prevent chronic conditions. The company has developed a cutting-edge AI-driven platform designed to predict and mitigate the risk of food allergies, eczema, and related conditions. With a dedicated team of licensed dietitian nutritionists and innovative technologies, MyOr promotes evidence-based practices and nutrition strategies that can prevent many chronic conditions. The company is committed to improving health outcomes and empowering healthcare providers and caregivers with personalized solutions to eliminate preventable conditions, creating a healthier future for our clients.
Cumulative Funding Raised Over Time ($)
$500KApr 2018
$5.5MAug 2022
Latest News
growth-positive
MyOr Diagnostics Brings Together a Network of Nutrition Experts to Educate Parents on Food Allergy Nutrition Strategies
MyOr Diagnostics has expanded its network of nutritionists across 20 states in Mexico to help parents with innovative tools and nutrition strategies for infants. The network will use MyOrs technology through the MyorCare platform to help safeguard babies against food allergies and atopic dermatitis. The companys platform uses an AI algorithm to predict the risk of these conditions in healthy newborns and provides resources and practices to reduce the risk. The company also offers access to personally tailored consumer products to prevent the development of these conditions.
Expand
Growth-Positive
MyOr Diagnostics Wins Prestigious BNEW Prize for Best New Health Startup
MyOr Diagnostics, a health startup focused on revolutionizing pediatric healthcare, has been awarded the BNEW Prize for Best New Health Startup at the Barcelona New Economy Week (BNEW) event. The companys lead product, MyorCare, and its innovative approach to preventative health captured the attention of professionals, investors, and innovators at the event. The recognition highlights MyOrs commitment to delivering cutting-edge solutions that can transform healthcare and improve lives. The company was also approached by other startups, industry leaders, and investors, further solidifying its place within the global health tech ecosystem.
CustomersPartnersInvestment
growth-positive
Israeli Baby Formula Company Seeks US Approval To Ease Shortage - Yid Info
The US Food and Drug Administration has issued emergency guidance to allow the import of infant formulas produced abroad, in response to a shortage in the country. Israeli health-tech company MyOr, which has a Mexican subsidiary AlphaCare that produces and markets its formulas, is among the companies seeking FDA approval. MyOr, founded in 2018, provides preventive healthcare solutions for infants at risk, with a focus on food allergies and nutritional sufficiency. The company has 200,000 cans of formula ready to be shipped, with a capacity to produce another 250,000 a month.
CustomersExpand
Israeli tech company aims to solve US baby formula crisis - I24NEWS
growth-positive
This startup aims to predict and prevent allergies in babies
Israeli startup MyOR uses AI models and predictive data to forecast which newborns are at risk of developing food allergies and atopic dermatitis. The company provides pediatricians with a tool to guide parents on how to prevent allergies. MyOR tests babies skin barriers and considers parameters such as family history, pregnancy, childbirth, and infancy to create personalized risk reports. The company offers physical products to support parents in preventing allergies. MyOR is targeting the US market and has received investment from angel and private investors. The startup collaborates with leading research groups and claims to provide a holistic solution for predicting and preventing allergies.
Customers
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $5.5M |
| Last funding | $5M |
| Stage | A |
| Rounds | 2 |
| Investors | 6 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | www.myorthrive.com |
| Careers | Careers page |
Locations
Bareket Street 29, Zikhron Ya'akov, Israel
Photos & Videos
1 item(s)
MyOr Business
Business models
B2C, B2B2C
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcarePatient EngagementMedical Decision SupportTarget Customer
Financial ServicesFinancial ProductsInsuranceConsumersDemographics & FamilyChildrenHealthcare & Life SciencesHealthcareProvidersCore Technology
Artificial IntelligenceMachine LearningTags (22)
medical-devicesdigital-healthcareartificial-intelligencepersonalizationnutritionskin-caremachine-learningdigital-therapeuticsinsurance-companiespediatricschildrendermatologypharma-companiesbabiesactionable-insightspersonalized-medicinenon-invasivehealthcare-providerspredictive-analyticsimage-processingmonitoringpersonalized-treatmentGeographic Markets
AustraliaUnited StatesMyOr Financials
$5.5M
Total funding
Undisclosed
Capital raised
$5M
Last funding
A
Funding stage
2
Total rounds
6
Investors
Cumulative Funding Raised Over Time ($)
$500KApr 2018
$5.5MAug 2022
Private Equity Funding
A Round
Aug 2022
$5M
Arancia International, Mercantile Partners, Nesher, Polaris Partners, Irlk Ventures
Seed
Apr 2018
$500K
ILRK Ventures, Arancia International
MyOr Lifecycle
Cumulative Funding Raised Over Time
$500KApr 2018
$5.5MAug 2022
All Events
A Round
Aug 2022
$5M
Arancia International, Mercantile Partners, Nesher, Polaris Partners, Irlk Ventures
Seed
Apr 2018
$500K
ILRK Ventures, Arancia International
MyOr News
8 articles
growth-positive
MyOr Diagnostics Brings Together a Network of Nutrition Experts to Educate Parents on Food Allergy Nutrition Strategies
MyOr Diagnostics has expanded its network of nutritionists across 20 states in Mexico to help parents with innovative tools and nutrition strategies for infants. The network will use MyOrs technology through the MyorCare platform to help safeguard babies against food allergies and atopic dermatitis. The companys platform uses an AI algorithm to predict the risk of these conditions in healthy newborns and provides resources and practices to reduce the risk. The company also offers access to personally tailored consumer products to prevent the development of these conditions.
Expand
Growth-Positive
MyOr Diagnostics Wins Prestigious BNEW Prize for Best New Health Startup
MyOr Diagnostics, a health startup focused on revolutionizing pediatric healthcare, has been awarded the BNEW Prize for Best New Health Startup at the Barcelona New Economy Week (BNEW) event. The companys lead product, MyorCare, and its innovative approach to preventative health captured the attention of professionals, investors, and innovators at the event. The recognition highlights MyOrs commitment to delivering cutting-edge solutions that can transform healthcare and improve lives. The company was also approached by other startups, industry leaders, and investors, further solidifying its place within the global health tech ecosystem.
CustomersPartnersInvestment
growth-positive
Israeli Baby Formula Company Seeks US Approval To Ease Shortage - Yid Info
The US Food and Drug Administration has issued emergency guidance to allow the import of infant formulas produced abroad, in response to a shortage in the country. Israeli health-tech company MyOr, which has a Mexican subsidiary AlphaCare that produces and markets its formulas, is among the companies seeking FDA approval. MyOr, founded in 2018, provides preventive healthcare solutions for infants at risk, with a focus on food allergies and nutritional sufficiency. The company has 200,000 cans of formula ready to be shipped, with a capacity to produce another 250,000 a month.
CustomersExpand
Israeli tech company aims to solve US baby formula crisis - I24NEWS
growth-positive
This startup aims to predict and prevent allergies in babies
Israeli startup MyOR uses AI models and predictive data to forecast which newborns are at risk of developing food allergies and atopic dermatitis. The company provides pediatricians with a tool to guide parents on how to prevent allergies. MyOR tests babies skin barriers and considers parameters such as family history, pregnancy, childbirth, and infancy to create personalized risk reports. The company offers physical products to support parents in preventing allergies. MyOR is targeting the US market and has received investment from angel and private investors. The startup collaborates with leading research groups and claims to provide a holistic solution for predicting and preventing allergies.
Customers
growth-positive
MYOR to Launch NURTURE Precision Infant Care™ - Early Intervention Platform for Tackling Childhood Allergies
MedTech startup MYOR has launched the NURTURE Precision Infant Care platform, which accurately identifies high-allergy risk infants and provides guidelines for prevention and care. The platform will be rolled out to clinics across the US in the coming months. The solution aims to empower caregivers and health professionals in managing childhood allergies, which affect approximately 8% of children. NURTURE utilizes predictive analytics and a user-friendly web platform to provide personalized plans, advice, and products for at-risk newborns. The collaboration with Horizon Pediatrics & Primary Care in Denver, Colorado has been successful. The article highlights the $30 billion annual financial burden of childhood allergies on the US government.
Customers
growth-positive
MYOR Begins US Commercialization of its Breakthrough Platform to Prevent Allergic Conditions - JLM-BioCity
MYOR, a leading digital health company, has launched its NURTURE Precision Infant Care platform in the United States. NURTURE is a clinical decision support tool that provides personalized risk analysis and protection plans to prevent food allergies and atopic dermatitis in newborns. The platform assesses biological and environmental risk factors and generates a risk report for parents. MYOR aims to eliminate unnecessary diseases and discomfort in infants and empower parents to take control of their newborns health. The company is seeking round A funding for further expansion. MYOR has received recognition, including the MedTech Breakthrough Award and Israels Most Promising Digital Health Startup Award.
CustomersInvestment
https://www.5-ht.com/en/2020/02/17/what-our-skin-tells-us-about-our-body/
MyOr Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 39 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 15 classification IDs that could be used for matching.
MyOr Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Yotam Maman |
| Registrar ID | 515811206 |
| Crunchbase | myor-diagnostics |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2022-10-17T00:00:00.000Z |
| Created | 2018-10-02T00:00:00.000Z |
| Claimed | Yes |